Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 55

1.

Treatment preferences and involvement in treatment decision making of patients with endometrial cancer and clinicians.

Kunneman M, Pieterse AH, Stiggelbout AM, Nout RA, Kamps M, Lutgens LC, Paulissen J, Mattheussens OJ, Kruitwagen RF, Creutzberg CL.

Br J Cancer. 2014 Jun 12. doi: 10.1038/bjc.2014.322. [Epub ahead of print]

PMID:
24921911
[PubMed - as supplied by publisher]
2.

Second primary cancers in survivors of cervical cancer in the Netherlands: Implications for prevention and surveillance.

Arnold M, Liu L, Kenter GG, Creutzberg CL, Coebergh JW, Soerjomataram I.

Radiother Oncol. 2014 May 12. pii: S0167-8140(14)00174-1. doi: 10.1016/j.radonc.2014.04.011. [Epub ahead of print]

PMID:
24833558
[PubMed - as supplied by publisher]
3.

Screening for coronary artery disease after mediastinal irradiation in Hodgkin lymphoma survivors: phase II study of indication and acceptance†.

Daniëls LA, Krol AD, de Graaf MA, Scholte AJ, Van't Veer MB, Putter H, de Roos A, Schalij MJ, Creutzberg CL.

Ann Oncol. 2014 Jun;25(6):1198-203. doi: 10.1093/annonc/mdu130. Epub 2014 Mar 31.

PMID:
24692582
[PubMed - in process]
4.

High concordance of molecular tumor alterations between pre-operative curettage and hysterectomy specimens in patients with endometrial carcinoma.

Stelloo E, Nout RA, Naves LC, Ter Haar NT, Creutzberg CL, Smit VT, Bosse T.

Gynecol Oncol. 2014 May;133(2):197-204. doi: 10.1016/j.ygyno.2014.02.012. Epub 2014 Feb 18.

PMID:
24556061
[PubMed - indexed for MEDLINE]
5.

Chronic fatigue in Hodgkin lymphoma survivors and associations with anxiety, depression and comorbidity.

Daniëls LA, Oerlemans S, Krol AD, Creutzberg CL, van de Poll-Franse LV.

Br J Cancer. 2014 Feb 18;110(4):868-74. doi: 10.1038/bjc.2013.779. Epub 2014 Jan 16.

PMID:
24434433
[PubMed - indexed for MEDLINE]
6.

Gynecologic Cancer InterGroup (GCIG) Endometrial Cancer Clinical Trials Planning Meeting: taking endometrial cancer trials into the translational era.

Creutzberg CL, Kitchener HC, Birrer MJ, Landoni F, Lu KH, Powell M, Aghajanian C, Edmondson R, Goodfellow PJ, Quinn M, Salvesen HB, Thomas G; GCIG Endometrial Cancer Clinical Trials Planning Meeting.

Int J Gynecol Cancer. 2013 Oct;23(8):1528-34. doi: 10.1097/IGC.0b013e3182a26edb.

PMID:
24257568
[PubMed - indexed for MEDLINE]
7.

Self-reported sexual, bowel and bladder function in cervical cancer patients following different treatment modalities: longitudinal prospective cohort study.

Pieterse QD, Kenter GG, Maas CP, de Kroon CD, Creutzberg CL, Trimbos JB, Ter Kuile MM.

Int J Gynecol Cancer. 2013 Nov;23(9):1717-25. doi: 10.1097/IGC.0b013e3182a80a65.

PMID:
24172106
[PubMed - indexed for MEDLINE]
8.

Long-term risk of secondary skin cancers after radiation therapy for Hodgkin's lymphoma.

Daniëls LA, Krol AD, Schaapveld M, Putter H, Jansen PM, Marijt EW, van Leeuwen FE, Creutzberg CL.

Radiother Oncol. 2013 Oct;109(1):140-5. doi: 10.1016/j.radonc.2013.06.041. Epub 2013 Aug 7.

PMID:
23932152
[PubMed - in process]
9.

Persisting fatigue in Hodgkin lymphoma survivors: a systematic review.

Daniëls LA, Oerlemans S, Krol AD, van de Poll-Franse LV, Creutzberg CL.

Ann Hematol. 2013 Aug;92(8):1023-32. doi: 10.1007/s00277-013-1793-2. Epub 2013 Jun 1. Review.

PMID:
23728609
[PubMed - indexed for MEDLINE]
10.

Loss of ARID1A expression and its relationship with PI3K-Akt pathway alterations, TP53 and microsatellite instability in endometrial cancer.

Bosse T, ter Haar NT, Seeber LM, v Diest PJ, Hes FJ, Vasen HF, Nout RA, Creutzberg CL, Morreau H, Smit VT.

Mod Pathol. 2013 Nov;26(11):1525-35. doi: 10.1038/modpathol.2013.96. Epub 2013 May 24.

PMID:
23702729
[PubMed - indexed for MEDLINE]
11.

Cancer of the corpus uteri.

Amant F, Mirza MR, Creutzberg CL.

Int J Gynaecol Obstet. 2012 Oct;119 Suppl 2:S110-7. doi: 10.1016/S0020-7292(12)60024-1. No abstract available.

PMID:
22999502
[PubMed - indexed for MEDLINE]
12.

Long-term clinical outcome of patients with soft tissue sarcomas treated with limb-sparing surgery and postoperative radiotherapy.

Felderhof JM, Creutzberg CL, Putter H, Nout RA, Bovée JV, Dijkstra PD, Hartgrink HH, Marijnen CA.

Acta Oncol. 2013 May;52(4):745-52. doi: 10.3109/0284186X.2012.709947. Epub 2012 Aug 30.

PMID:
22934557
[PubMed - indexed for MEDLINE]
13.

Perceived information provision and satisfaction among lymphoma and multiple myeloma survivors--results from a Dutch population-based study.

Oerlemans S, Husson O, Mols F, Poortmans P, Roerdink H, Daniels LA, Creutzberg CL, van de Poll-Franse LV.

Ann Hematol. 2012 Oct;91(10):1587-95. doi: 10.1007/s00277-012-1495-1. Epub 2012 May 26.

PMID:
22638756
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Improved risk assessment of endometrial cancer by combined analysis of MSI, PI3K-AKT, Wnt/β-catenin and P53 pathway activation.

Nout RA, Bosse T, Creutzberg CL, Jürgenliemk-Schulz IM, Jobsen JJ, Lutgens LC, van der Steen-Banasik EM, van Eijk R, Ter Haar NT, Smit VT.

Gynecol Oncol. 2012 Sep;126(3):466-73. doi: 10.1016/j.ygyno.2012.05.012. Epub 2012 May 15.

PMID:
22609107
[PubMed - indexed for MEDLINE]
15.

Five-year quality of life of endometrial cancer patients treated in the randomised Post Operative Radiation Therapy in Endometrial Cancer (PORTEC-2) trial and comparison with norm data.

Nout RA, Putter H, Jürgenliemk-Schulz IM, Jobsen JJ, Lutgens LC, van der Steen-Banasik EM, Mens JW, Slot A, Stenfert Kroese MC, Nijman HW, van de Poll-Franse LV, Creutzberg CL.

Eur J Cancer. 2012 Jul;48(11):1638-48. doi: 10.1016/j.ejca.2011.11.014. Epub 2011 Dec 14.

PMID:
22176868
[PubMed - indexed for MEDLINE]
Free Article
16.

The role of radiotherapy in endometrial cancer: current evidence and trends.

Creutzberg CL, Nout RA.

Curr Oncol Rep. 2011 Dec;13(6):472-8. doi: 10.1007/s11912-011-0191-y. Review.

PMID:
21845420
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Fifteen-year radiotherapy outcomes of the randomized PORTEC-1 trial for endometrial carcinoma.

Creutzberg CL, Nout RA, Lybeert ML, Wárlám-Rodenhuis CC, Jobsen JJ, Mens JW, Lutgens LC, Pras E, van de Poll-Franse LV, van Putten WL; PORTEC Study Group.

Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):e631-8. doi: 10.1016/j.ijrobp.2011.04.013. Epub 2011 Jun 2.

PMID:
21640520
[PubMed - indexed for MEDLINE]
Free Article
18.

Adjuvant chemotherapy for endometrial cancer: unproven.

Creutzberg CL.

Int J Gynecol Cancer. 2010 Oct;20(7):1105-8. Review.

PMID:
21495211
[PubMed - indexed for MEDLINE]
19.

Long-term outcome and quality of life of patients with endometrial carcinoma treated with or without pelvic radiotherapy in the post operative radiation therapy in endometrial carcinoma 1 (PORTEC-1) trial.

Nout RA, van de Poll-Franse LV, Lybeert ML, Wárlám-Rodenhuis CC, Jobsen JJ, Mens JW, Lutgens LC, Pras B, van Putten WL, Creutzberg CL.

J Clin Oncol. 2011 May 1;29(13):1692-700. doi: 10.1200/JCO.2010.32.4590. Epub 2011 Mar 28.

PMID:
21444867
[PubMed - indexed for MEDLINE]
20.

Point: Vaginal brachytherapy should be a standard adjuvant treatment for intermediate-risk endometrial cancer.

Nout RA, Creutzberg CL.

Brachytherapy. 2011 Jan-Feb;10(1):1-3. doi: 10.1016/j.brachy.2010.11.002. No abstract available.

PMID:
21251618
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk